Germany's Alzchem H1 sales rise on strong demand for specialty chemical ingredients
Germany's Alzchem H1 sales rise on strong demand for specialty chemical ingredients
Overview
Germany specialty chemicals producer's H1 sales rose 6%, EBITDA up 14% yr/yr
Growth driven by higher sales volumes, improved prices, and demand in specialty segments
Company confirms 2026 forecast, expects further increases in sales and EBITDA
Outlook
Alzchem confirms forecast for 2026, expects further increases in sales and EBITDA
Company sees strong demand for specialty chemical ingredients supporting future growth
Alzchem expects expanded production capacity to meet rising customer demand in H2 2026
Result Drivers
SPECIALTY CHEMICALS DEMAND - Growth in human nutrition, defense, and custom manufacturing segments drove sales and profitability
HIGHER VOLUMES AND PRICES - Increased sales volumes and improved price levels supported revenue and margin growth
BASICS & INTERMEDIATES IMPACTED - Segment sales declined slightly due to challenging pharma and agriculture markets and furnace renovation
Company press release: ID:nEQ1x8cr3a
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
H1 EBITDA |
| EUR 64.50 mln |
|
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the specialty chemicals peer group is "buy"
Wall Street's median 12-month price target for Alzchem Group AG is €198.50, about 14.1% above its July 29 closing price of €174.00
The stock recently traded at 23 times the next 12-month earnings vs. a P/E of 25 three months ago
Reuters Recommended Reads
July 29 - Germany's H&R KGaA H1 EBITDA more than doubles on higher feedstock prices
July 29 - Germany's BASF Q2 net income surges on coatings sale
July 28 - UK's Croda H1 sales rise on Consumer Care growth
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Recent news on AlzChem AG
See all newsGermany's Alzchem H1 sales rise on strong demand for specialty chemical ingredients
Brief: Alzchem Confirms Full-year 2026 Outlook
Brief: Alzchem Selects Bushy Park, South Carolina For Nitroguanidine Production Facility
Germany's Alzchem jumps 6.5% after defence contractor CSG secures 20% stake
Brief: Alzchem Group AG Further Increase In Shareholding By Czechoslovak Group